-+ 0.00%
-+ 0.00%
-+ 0.00%

Merck Kgaa Agrees To Acquire Rapid Micro Biosystems At Price Of $0.75/Shr In All-Cash Transaction

Benzinga·11/16/2026 14:28:53
Listen to the news

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced it has signed a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, has agreed to acquire, subject to the terms and conditions set forth in the agreement, all outstanding shares of Rapid Micro Biosystems at a price of $0.75 per share in an all-cash transaction.

Transaction Details

The transaction is expected to close in December 2026, subject to the successful completion of the tender offer, including satisfaction of the minimum tender condition, and other customary closing conditions. Following completion of the transaction, Rapid Micro Biosystems will become part of the Life Science business of Merck KGaA, Darmstadt, Germany.